Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kolon Corporation (002020.KS)
Gwacheon-si, KR
Founded in Gwacheon, South Korea, in 1957, Kolon Corporation operates as a diversified enterprise, primarily supporting and managing its affiliated businesses. Its operations extend to intellectual property licensing, market research, and management consulting, serving both domestic and international markets. The company manufactures a comprehensive range of industrial and chemical products. These include tire cords, airbags, polyester spunbond, technical yarns, aramid products, and various films such as polyester, nylon, and coated films. It also produces DFR materials, overcoats, beads, hydrocarbon, phenolic, and epoxy resins, along with PU/TPU products and glass-reinforced plastic pipes. Additionally, Kolon supplies nylon and polyester fibers, as well as woven, knit, and high-performance functional fabrics. Beyond manufacturing, Kolon is active in commodity trading, dealing in steel, natural resources, and chemicals. Its construction division undertakes residential, industrial plant, civil engineering, and environmental projects. The company also specializes in automotive components, fabricating car seat modules, fabrics, and car mats. Furthermore, it develops specialty fibers like artificial turfs, polypropylene staple fibers, Bicomponent staple fiber, GEONIC, Cuprus, HeaTex, and polyester filaments. Kolon maintains a significant presence in the pharmaceutical and healthcare sectors. It offers over-the-counter medicines, the TRAMOL sustained relief painkiller and anti-inflammatory, active pharmaceutical ingredients, and biopharmaceuticals such as Tissuegene. The company also manages approximately 150 drugstores under the W-Store brand. In real estate and hospitality, Kolon develops properties and manages hotels, condominiums, and golf resorts. Its leisure operations include a shopping mall, a pet theme park, and themed toilets. Further diversifying its portfolio, Kolon operates Sweet Meal cafés, serving pastries, coffee, cheesecakes, and beverages. It supplies antimicrobial products, various PA, PBT, and POM base and compound resins, and retails both hardware and software. The company also delivers IT and business process outsourcing, alongside IT convergence services. Finally, Kolon is deeply involved in water-related environmental businesses, covering sewage and wastewater treatment, including the provision of materials, systems, equipment, and the operation of water treatment facilities. It also runs an industrial supply retail operation.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.91% | -11.13% | +0.95% | -1.84% | +31.89% | +39.98% | +184.00% | +217.12% | +102.86% | +17.46% | +906.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%-3.4% Q1'26: +1.1% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%-186.9% Q1'26: +174.4% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%-4.1% Q1'26: +4.2% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%-2.0% Q1'26: +3.0% (vs Q1'25)
-
ROIC Conglomerates: +4.7%-2.5% Q1'26: +3.6% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%+25.5% Q1'26: +5.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×-135.09× Q1'26: 10.06× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
5.89T
est: 4.78B (+123,224.2%)
|
6.03T
est: 961.50B (+527.0%)
|
5.82T
est: 1.15T (+405.3%)
|
6.32T
6.32T – 6.32T
+448.6% YoY
|
6.76T
6.76T – 6.76T
+7.0% YoY
|
| EBITDA |
221.14B
est: 282.50M (+78,181.5%)
|
496.27B
est: 46.11B (+976.3%)
|
-20.18B
est: 55.25B (-136.5%)
|
303.11B
303.11B – 303.11B
+448.6% YoY
|
324.35B
324.35B – 324.35B
+7.0% YoY
|
| EBIT |
137.60B
est: 210.12M (+65,387.1%)
|
398.39B
est: 31.76B (+1,154.2%)
|
-114.28B
est: 38.06B (-400.2%)
|
208.81B
208.81B – 208.81B
+448.6% YoY
|
223.44B
223.44B – 223.44B
+7.0% YoY
|
| Net Income |
8.57B
|
170.31B
est: 16.05B (+961.1%)
|
-158.47B
est: 16.73B (-1,047.0%)
|
92.40B
92.40B – 92.40B
+452.2% YoY
|
122.31B
122.31B – 122.31B
+32.4% YoY
|
| SGA |
115.18B
est: 90.42M (+127,287.4%)
|
139.08B
est: 19.38B (+617.7%)
|
137.80B
est: 23.22B (+493.4%)
|
127.39B
127.39B – 127.39B
+448.6% YoY
|
136.32B
136.32B – 136.32B
+7.0% YoY
|
| EPS |
625.15
|
12,424.00
est: 932.78 (+1,231.9%)
|
-10,791.00
est: 972.47 (-1,209.7%)
|
5,370.00
5,370.00 – 5,370.00
+452.2% YoY
|
7,108.00
7,108.00 – 7,108.00
+32.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex KOSPI 226490.KS | 0.02% | 153.2K | 0.15% |
| 2 | Schwab Fundamental International Small Company Index ETF FNDC | 0.01% | 420.3K | 0.39% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 544.6K | 0.39% |
| 4 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 36.0K | 0.44% |
| 5 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 9.2K | 0.56% |
| 6 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 215.5K | 0.29% |
| 7 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 103.7K | 0.28% |
| 8 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 42.9K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Beomyong Oh | Secretary | — | male |
| ByeongJin Yu | Executive Director & Head of Ethics Management Office | — | male |
| Byung-Deok Ahn | Chief Executive Officer, President & Vice Chairman | — | male |
| Kyu-Ho Lee | Vice Chairman, President & Chief Executive Officer | — | male |
| Sanghyun Ahn | Head of Strategy | — | male |
| Sujin Lee | MD & Director | — | female |
| YeongCheol Kim | MD & Personnel Manager | — | male |
| YunSeok Ok | Executive Director & Head of Business Management | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002020.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
